Observational Study of the Effectiveness and Safety of Vismodegib (Erivedge) in Patients Treated in Argentina
Phase of Trial: Phase II
Latest Information Update: 10 Sep 2016
At a glance
- Drugs Vismodegib (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- Sponsors Roche
- 30 Aug 2016 Planned End Date changed from 1 Jun 2016 to 1 Jun 2017.
- 30 Aug 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017.
- 30 Aug 2016 Status changed from not yet recruiting to recruiting.